Item 1(a). | Name of Issuer: |
IDEAYA Biosciences, Inc. (the “Issuer”)
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
7000 Shoreline Court, Suite 350, South San Francisco, California 94080
Item 2(a). | Names of Persons Filing: |
The names of the persons filing this report (collectively, the “Reporting Persons”) are:
Perceptive Advisors LLC (“Perceptive Advisors”)
Joseph Edelman (“Mr. Edelman”)
Perceptive Life Sciences Master Fund, Ltd. (the “Master Fund”)
Item 2(b). | Address of Principal Business Office or, if None, Residence: |
The address of the principal business office of each of the Reporting Persons is:
51 Astor Place, 10th Floor
New York, NY 10003
Perceptive Advisors is a Delaware limited liability company
Mr. Edelman is a United States citizen
The Master Fund is a Cayman Islands corporation
Item 2(d). | Title of Class of Securities: |
Common Shares (“Common Stock”)
45166A 102
Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or240.13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page to this Schedule 13G. The ownership percentages reported are based on 19,478,654 outstanding shares of Common Stock after giving effect to the Issuer’s initial public offering, as reported in the Issuer’s prospectus filed on May 24, 2019.